Prevymis (letermovir) - Merck (MSD)
https://distribution.us.m-anage.com/from.storage?image=iI8mZKVyQCOb0f6sZEQvourp4Y8uCLVBY7ZS0AtwQWSj7J4EmgqgUJ_uU8F1Lm3y0
 
Shunto Kawamura, M.D. 1; Hideki Nakasone, MD, PhD 1,2; Yuki Honjo, M.D. 1,3; Junko Takeshita, M.D. 1; Yukiko Misaki, M.D. 1; Kosuke Takano, MD 1; Kazuki Yoshimura, M.D. 1; Koki Hashino, M.D. 1; Kaisuke Yamamoto, M.D. 1; Yuya Nakata, M.D. 1; Takuto Ishikawa, MD 1; Akari Matsuoka, M.D. 1; Tomohiro Meno, M.D. 1; Yuhei Nakamura, M.D. 1; Masakatsu Kawamura, M.D. 1; Nozomu Yoshino, M.D. 1; Ayumi Gomyo, M.D. 1; Masaharu Tamaki, MD, PhD 1; Machiko Kusuda, M.D., Ph.D. 1; Shun-ichi Kimura, M.D., Ph.D. 1; Shinichi Kako, M.D., Ph.D. 1; Yoshinobu Kanda, MD, PhD 1
 
Jan 8, 2026
 
Prev Next